New Avenues for Targeted Therapies and Biomarkers In Anaplastic Large Cell Lymphoma

References

• Turner SD , LamantL , KennerL , BrugieresL . Anaplastic large cell lymphoma in paediatric and young adult patients . Br. J. Haematol.173 ( 4 ), 560 – 572 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Morris SW , KirsteinMN , ValentineMBet al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma . Science263 ( 5151 ), 1281 – 1284 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Duyster J , BaiRY , MorrisSW . Translocations involving anaplastic lymphoma kinase (ALK) . Oncogene20 ( 40 ), 5623 – 5637 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Chiarle R , SimmonsWJ , CaiHet al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target . Nat. Med.11 ( 6 ), 623 – 629 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Crescenzo R , AbateF , LasorsaEet al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma . Cancer Cell27 ( 4 ), 516 – 532 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Schiefer AI , VeselyP , HasslerMR , EggerG , KennerL . The role of AP-1 and epigenetics in ALCL . Front. Biosci.7 , 226 – 235 ( 2015 ).
   Google Scholar
• Ambrogio C , MartinengoC , VoenaCet al. NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells . Cancer Res.69 ( 22 ), 8611 – 8619 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zhang Q , WangHY , WoetmannA , RaghunathPN , OdumN , WasikMA . STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes . Blood108 ( 3 ), 1058 – 1064 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Hassler MR , PulvererW , LakshminarasimhanRet al. Insights into the pathogenesis of anaplastic large-cell lymphoma through genome-wide DNA methylation profiling . Cell Rep.17 ( 2 ), 596 – 608 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Joosten M , SeitzV , ZimmermannKet al. Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype . Haematologica98 ( 2 ), 247 – 254 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Malcolm TI , HodsonDJ , MacintyreEA , TurnerSD . Challenging perspectives on the cellular origins of lymphoma . Open Biol.6 ( 9 ), pii: 160232 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Foss HD , AnagnostopoulosI , AraujoIet al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules . Blood88 ( 10 ), 4005 – 4011 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Stein H , MasonDY , GerdesJet al. The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed–Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells . Blood66 ( 4 ), 848 – 858 ( 1985 ).
   PubMed Web of Science ®Google Scholar
• Moti N , MalcolmT , HamoudiRet al. Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin . Oncogene34 ( 14 ), 1843 – 1852 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ji H , EhrlichLI , SeitaJet al. Comprehensive methylome map of lineage commitment from haematopoietic progenitors . Nature467 ( 7313 ), 338 – 342 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Rodriguez RM , Suarez-AlvarezB , Mosen-AnsorenaDet al. Regulation of the transcriptional program by DNA methylation during human alphabeta T-cell development . Nucleic Acids Res.43 ( 2 ), 760 – 774 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Laimer D , DolznigH , KollmannKet al. PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas . Nat. Med.18 ( 11 ), 1699 – 1704 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Staber PB , VeselyP , HaqNet al. The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling . Blood110 ( 9 ), 3374 – 3383 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Le Deley MC , RosolenA , WilliamsDMet al. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial . J. Clin. Oncol.28 ( 25 ), 3987 – 3993 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Mussolin L , Damm-WelkC , PillonMet al. Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis . Leukemia27 ( 2 ), 416 – 422 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gambacorti-Passerini C , MessaC , PoglianiEM . Crizotinib in anaplastic large-cell lymphoma . N Engl. J. Med.364 ( 8 ), 775 – 776 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Gambacorti-Passerini C , MussolinL , BrugieresL . Abrupt relapse of ALK-positive lymphoma after discontinuation of crizotinib . N. Engl. J. Med.374 ( 1 ), 95 – 96 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Gainor JF , ShawAT . Emerging paradigms in the development of resistance to tyrosine kinase inhibitors in lung cancer . J. Clin. Oncol.31 ( 31 ), 3987 – 3996 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chiappinelli KB , StrisselPL , DesrichardAet al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses . Cell162 ( 5 ), 974 – 986 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Roulois D , Loo YauH , SinghaniaRet al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts . Cell162 ( 5 ), 961 – 973 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hassler MR , KlisaroskaA , KollmannKet al. Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine in anaplastic large cell lymphoma . Biochimie94 ( 11 ), 2297 – 2307 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jones PA , IssaJP , BaylinS . Targeting the cancer epigenome for therapy . Nat. Rev. Genet.17 ( 10 ), 630 – 641 ( 2016 ).
   PubMed Web of Science ®Google Scholar